77 related articles for article (PubMed ID: 34045552)
1. Integrative genomic analysis implicates ERCC6 and its interaction with ERCC8 in susceptibility to breast cancer.
Moslehi R; Tsao HS; Zeinomar N; Stagnar C; Fitzpatrick S; Dzutsev A
Sci Rep; 2020 Dec; 10(1):21276. PubMed ID: 33277540
[TBL] [Abstract][Full Text] [Related]
2. Identification of
Li J; Han S; Zhang C; Luo Y; Wang L; Wang P; Wang Y; Xia Q; Wang X; Wei B; Ma J; Li H; Guo Y
Front Oncol; 2021; 11():655709. PubMed ID: 34046351
[TBL] [Abstract][Full Text] [Related]
3. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.
International Mismatch Repair Consortium
Lancet Oncol; 2021 Jul; 22(7):1014-1022. PubMed ID: 34111421
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic landscape of early age onset of colorectal cancer identifies novel genes and pathways in Indian CRC patients.
Singh MP; Rai S; Singh NK; Srivastava S
Sci Rep; 2021 Jun; 11(1):11765. PubMed ID: 34083590
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer.
Joo JE; Clendenning M; Wong EM; Rosty C; Mahmood K; Georgeson P; Winship IM; Preston SG; Win AK; Dugué PA; Jayasekara H; English D; Macrae FA; Hopper JL; Jenkins MA; Milne RL; Giles GG; Southey MC; Buchanan DD
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070516
[TBL] [Abstract][Full Text] [Related]
6. A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants.
Wiik MU; Evans TJ; Belhadj S; Bolton KA; Dymerska D; Jagmohan-Changur S; Capellá G; Kurzawski G; Wijnen JT; Valle L; Vasen HFA; Lubinski J; Scott RJ; Talseth-Palmer BA
Sci Rep; 2021 May; 11(1):11401. PubMed ID: 34059744
[TBL] [Abstract][Full Text] [Related]
7. SPATA20 deficiency enhances the metastatic and angiogenic potential of cancer cells by promoting HIF-1α synthesis.
Choi S; Yoo S; Jeon M; Park S; Choi Y; An J; Jeon S; Lee M; Yun JH; Park JW; Kim I
Am J Cancer Res; 2024; 14(2):727-743. PubMed ID: 38455399
[TBL] [Abstract][Full Text] [Related]
8. Detection of germline variants with pathogenic potential in 48 patients with familial colorectal cancer by using whole exome sequencing.
Singh AK; Talseth-Palmer B; Xavier A; Scott RJ; Drabløs F; Sjursen W
BMC Med Genomics; 2023 Jun; 16(1):126. PubMed ID: 37296477
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota display alternative profiles in patients with early-onset colorectal cancer.
Xiong H; Wang J; Chang Z; Hu H; Yuan Z; Zhu Y; Hu Z; Wang C; Liu Y; Wang Y; Wang G; Tang Q
Front Cell Infect Microbiol; 2022; 12():1036946. PubMed ID: 36389150
[TBL] [Abstract][Full Text] [Related]
10. Potential Involvement of
Quintana I; Mur P; Terradas M; García-Mulero S; Aiza G; Navarro M; Piñol V; Brunet J; Moreno V; Sanz-Pamplona R; Capellá G; Valle L
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158968
[TBL] [Abstract][Full Text] [Related]
11. From APC to the genetics of hereditary and familial colon cancer syndromes.
Olkinuora AP; Peltomäki PT; Aaltonen LA; Rajamäki K
Hum Mol Genet; 2021 Oct; 30(R2):R206-R224. PubMed ID: 34329396
[TBL] [Abstract][Full Text] [Related]
12. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.
Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A
World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863
[TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing identifies MAP3K1, MSH2, and MLH1 as potential cancer-predisposing genes in familial early-onset colorectal cancer.
Fatemi N; Tu SJ; Chung CC; Moghadam PK; Mojarad EN; Sadeghi A; Totonchi M; Aghdaei HA; Chang JG
Kaohsiung J Med Sci; 2023 Sep; 39(9):896-903. PubMed ID: 37314251
[TBL] [Abstract][Full Text] [Related]
14. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery.
Hahn MM; de Voer RM; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP; van Kessel AG
Cell Oncol (Dordr); 2016 Dec; 39(6):491-510. PubMed ID: 27279102
[TBL] [Abstract][Full Text] [Related]
15. Genetic predisposition to colorectal cancer: where we stand and future perspectives.
Valle L
World J Gastroenterol; 2014 Aug; 20(29):9828-49. PubMed ID: 25110415
[TBL] [Abstract][Full Text] [Related]
16. Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer.
Fernández-Rozadilla C; Álvarez-Barona M; Quintana I; López-Novo A; Amigo J; Cameselle-Teijeiro JM; Roman E; Gonzalez D; Llor X; Bujanda L; Bessa X; Jover R; Balaguer F; Castells A; Castellví-Bel S; Capellá G; Carracedo A; Valle L; Ruiz-Ponte C
Sci Rep; 2021 May; 11(1):11135. PubMed ID: 34045552
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas.
Arora S; Yan H; Cho I; Fan HY; Luo B; Gai X; Bodian DL; Vockley JG; Zhou Y; Handorf EA; Egleston BL; Andrake MD; Nicolas E; Serebriiskii IG; Yen TJ; Hall MJ; Golemis EA; Enders GH
Gastroenterology; 2015 Dec; 149(7):1872-1883.e9. PubMed ID: 26344056
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
